Bentham Science Logo

Current Drug Targets

Volume 20, 16 Issues, 2019
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Ranking and Category

  • 131st of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Contents

Current Drug Targets, Volume 18 - Number 3




Review Article


Review Article

Do We Need Full Donor Chimerism? How Alloreactive Cell Therapies without Substantial Engraftment Might Treat Hematologic Cancers

, 18(3): 281 - 295

Elizabeth F. Krakow, Hui-Sheng Ai, Brian Shaffer, Jean-Sebastien Delisle, Kai-Xun Hu and Anthony D. Sung


DOI: 10.2174/1389450116666150304103849



Review Article



Review Article

Immunomodulatory Drugs: Immune Checkpoint Agents in Acute Leukemia

, 18(3): 315 - 331

Hanna A. Knaus, Christopher G. Kanakry, Leo Luznik and Ivana Gojo


DOI: 10.2174/1389450116666150518095346



Review Article


Review Article

Small-Cell Lung Cancer: Clinical Management and Unmet Needs New Perspectives for an Old Problem

, 18(3): 341 - 362

Giuseppe Lo Russo, Marianna Macerelli, Marco Platania, Nicoletta Zilembo, Milena Vitali, Diego Signorelli, Claudia Proto, Monica Ganzinelli, Rosaria Gallucci, Francesco Agustoni, Gianpiero Fasola, Filippo de Braud and Marina Chiara Garassino


DOI: 10.2174/1389450117666160502152331



Review Article




Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

View Full Editorial Board

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Track Your Manuscript:


Scopus CiteScore Metrics: 1.18

Related Journals

Related eBooks

eBooks Catalog